Logo

People in the News: Edward Sitar, Elizabeth Adkins Czerepak

Mar 18, 2014
Premium

Cancer Genetics has appointed Edward Sitar as its new CFO, effective April 1.

Sitar joins the company from Aetna subsidiary Healthgen, where he held the same role. He was also CFO at ActiveHealth Management, Cadent Holdings, and Bioscrip.

Sitar replaces outgoing Elizabeth Adkins Czerepak, whose resignation from the position will be effective March 31.

Filed under

Microarrays & Multiplexing
microarrays
Cancer Genetics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.